Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats

Behavioral and Brain Functions

Volumn 9, Issue 1, 2013, Pages

  Luo, Jia ^a,b   Wang, Tao ^a   Liang, Shan ^a,b   Hu, Xu ^a   Li, Wei ^a,b   Jin, Feng ^a  

^a INSTITUTE OF PSYCHOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Anxiety; Depression; Gastrointestinal brain axis; Gender difference; Iodoacetamide induced gastritis

Indexed keywords

DRINKING WATER; ESTRADIOL; IODOACETAMIDE; MYELOPEROXIDASE; RNA; TESTOSTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; EXPERIMENTAL BEHAVIORAL TEST; EXPERIMENTAL GASTRITIS; FEMALE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ISOLATION; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; SUCROSE PREFERENCE TEST; TESTOSTERONE BLOOD LEVEL;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; FEMALE; GASTRITIS; IODOACETAMIDE; MALE; MOTOR ACTIVITY; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; STOMACH; STRESS, PSYCHOLOGICAL;

EID: 84890304588     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-9-46     Document Type: Article

References (89)

1. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011, 12:453-466. 3845678, 21750565.
2. Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011, 23:187-192. 10.1111/j.1365-2982.2010.01664.x, 21303428.
3. Suzana Tosic-Golubovic SM, Aleksandar N, Dusan L, Gordana N. Irritable bowel syndrome, anxiety, depression and personality characteristics. Psychiatr Danub 2010, 22:418-424.
4. Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Abenavoli L, Vonghia L, Cardone S, Leso V, Cossari A, Capristo E, Gasbarrini G. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract 2008, 62:1063-1069. 10.1111/j.1742-1241.2008.01763.x, 18422970.
5. Modabbernia M-J, Mansour-Ghanaei F, Imani A, Mirsafa-Moghaddam S-A, Sedigh-Rahimabadi M, Yousefi-Mashhour M, Joukar F, Atrkar-Roushan Z, Bidel S. Anxiety-depressive disorders among irritable bowel syndrome patients in Guilan. Iran. BMC Res Notes 2012, 5:112.
6. Van Oudenhove L, Vandenberghe J, Geeraerts B, Vos R, Persoons P, Fischler B, Demyttenaere K, Tack J. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation?. Gut 2008, 57:1666-1673. 10.1136/gut.2008.158162, 18625692.
7. Häuser WJK, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 2011, 17:621-632. 10.1002/ibd.21346, 20848528.
8. Filipović BF, Randjelovic T, Ille T, Markovic O, Milovanović B, Kovacevic N, Filipović BR. Anxiety, personality traits and quality of life in functional dyspepsia-suffering patients. Eur J Intern Med 2013, 24:83-86. 10.1016/j.ejim.2012.06.017, 22857883.
9. Tach XE, Tache Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007, 117:33-40. 10.1172/JCI30085, 1716215, 17200704.
10. Taché Y, Perdue MH. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004, 16:137-142. 10.1111/j.1743-3150.2004.00490.x, 15066020.
11. Mayer EA, Tillisch K, Bradesi S. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 2006, 24:919-933. 10.1111/j.1365-2036.2006.03078.x, 16948804.
12. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, Lu J, Khan WI, Corthesy-Theulaz I, Cherbut C, Bergonzelli GE, Collins SM. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139:2102-2112. e2101, 10.1053/j.gastro.2010.06.063, 20600016.
13. Liu L, Li Q, Sapolsky R, Liao M, Mehta K, Bhargava A, Pasricha PJ. Transient gastric irritation in the neonatal rats leads to changes in hypothalamic CRF expression, depression- and anxiety-like behavior as adults. PLoS ONE 2011, 6:e19498. 10.1371/journal.pone.0019498, 3093391, 21589865.
14. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012, 13:701-712. 10.1038/nrn3346, 22968153.
15. Heitkemper M, Jarrett M. Irritable bowel syndrome: does gender matter?. J Psychosom Res 2008, 64:583-587. 10.1016/j.jpsychores.2008.02.020, 18501258.
16. Cain K, Jarrett M, Burr R, Rosen S, Hertig V, Heitkemper M. Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Dig Dis Sci 2009, 54:1542-1549. 10.1007/s10620-008-0516-3, 3569485, 18979200.
17. Heitkemper MM, Jarrett ME. Update on irritable bowel syndrome and gender differences. Nutr Clin Pract 2008, 23:275-283. 10.1177/0884533608318672, 18595860.
18. Lesuis N, Befrits R, Nyberg F, van Vollenhoven R. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med 2012, 10:82. 10.1186/1741-7015-10-82, 3414735, 22853635.
19. Welén K, Faresjö T, Faresjö T. Functional dyspepsia affects women more than men in daily life: a case-control study in primary care. Gend Med 2008, 5:62-73. 10.1016/S1550-8579(08)80009-5, 18420167.
20. Shansky RM, Glavis-Bloom C, Lerman D, McRae P, Benson C, Miller K, Cosand L, Horvath TL, Arnsten AFT. Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol Psychiatry 2003, 9:531-538.
21. Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 2010, 62:155-198. 10.1124/pr.109.002071, 2879914, 20392807.
22. Painsipp E, Wultsch T, Shahbazian A, Edelsbrunner M, Kreissl MC, Schirbel A, Bock E, Pabst MA, Thoeringer CK, Huber HP, Holzer P. Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 2007, 150:522-536. 10.1016/j.neuroscience.2007.09.024, 17945426.
23. Karmeli F, Okon E, Rachmilewitz D. Sulphydryl blocker induced gastric damage is ameliorated by scavenging of free radicals. Gut 1996, 38:826-831. 10.1136/gut.38.6.826, 1383187, 8984018.
24. Strekalova T, Spanagel R, Bartsch D, Henn FA, Gass P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004, 29:2007-2017. 10.1038/sj.npp.1300532, 15266352.
25. Nosek K, Dennis K, Andrus B, Ahmadiyeh N, Baum A, Woods L, Redei E. Context and strain-dependent behavioral response to stress. Behav Brain Funct 2008, 4:23. 10.1186/1744-9081-4-23, 2424057, 18518967.
26. Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007, 2:322-328. 10.1038/nprot.2007.44, 3623971, 17406592.
27. Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997, 113:1224-1232. 10.1053/gast.1997.v113.pm9322517, 9322517.
28. Graff G, Gamache DA, Brady MT, Spellman JM, Yanni JM. Improved myeloperoxidase assay for quantitation of neutrophil influx in a rat model of endotoxin-induced uveitis. J Pharmacol Toxicol 1998, 39:169-178.
29. Jasnow AM, Schulkin J, Pfaff DW. Estrogen facilitates fear conditioning and increases corticotropin-releasing hormone mRNA expression in the central amygdala in female mice. Horm Behav 2006, 49:197-205. 10.1016/j.yhbeh.2005.06.005, 16083887.
30. Miyakoshi T, Kajiya H, Miyajima K, Takei M, Tobita M, Takekoshi S, Osamura RY. The expression of Wnt4 is regulated by estrogen via an estrogen receptor alpha-dependent pathway in rat pituitary growth hormone-producing cells. Acta Histochem Cytoc 2009, 42:205-213.
31. Marini F, Pozzato C, Andreetta V, Jansson B, Arban R, Domenici E, Carboni L. Single exposure to social defeat increases corticotropin-releasing factor and glucocorticoid receptor mRNA expression in rat hippocampus. Brain Res 2006, 1067:25-35. 10.1016/j.brainres.2005.10.002, 16360122.
32. Li J, Swope D, Raess N, Cheng L, Muller EJ, Radice GL. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of β-catenin signaling. Mol Cell Biol 2011, 31:1134-1144. 10.1128/MCB.01025-10, 3067899, 21245375.
33. Varghese AK, Verdú EF, Bercik P, Khan WI, Blennerhassett PA, Szechtman H, Collins SM. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology 2006, 130:1743-1753. 10.1053/j.gastro.2006.02.007, 16697738.
34. Bonaz BL, Bernstein CN. Brain-Gut interactions in inflammatory bowel disease. Gastroenterology 2013, 144:36-49. 10.1053/j.gastro.2012.10.003, 23063970.
35. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005, 54:1481-1491. 10.1136/gut.2005.064261, 1774724, 16162953.
36. Piqueras L, Corpa JM, Martínez J, Martínez V. Gastric hypersecretion associated to iodoacetamide-induced mild gastritis in mice. Naunyn Schmiedebergs Arch Pharmacol 2003, 367:140-150. 10.1007/s00210-002-0670-7, 12595955.
37. Ozaki N, Bielefeldt K, Sengupta JN, Gebhart GF. Models of gastric hyperalgesia in the rat. Am J Physiol Gastrointest Liver Physiol 2002, 283:G666-G676.
38. Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O'Connor JC. Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav 2012, 62:202-209. 10.1016/j.yhbeh.2012.03.010, 3425718, 22504306.
39. Strekalova T, Couch Y, Kholod N, Boyks M, Malin D, Leprince P, Steinbusch H. Update in the methodology of the chronic stress paradigm: internal control matters. Behav Brain Funct 2011, 7:9. 10.1186/1744-9081-7-9, 3111355, 21524310.
40. Strekalova T, Steinbusch HWM. Measuring behavior in mice with chronic stress depression paradigm. Prog Neuro-Psychopharmacol Biol Psychiatry 2010, 34:348-361. 10.1016/j.pnpbp.2009.12.014, 20026369.
41. Lamb K, Kang Y-M, Gebhart GF, Bielefeldt K. Gastric inflammation triggers hypersensitivity to acid in awake rats. Gastroenterology 2003, 125:1410-1418. 10.1016/j.gastro.2003.07.010, 14598257.
42. Smith GP, Jerome CRN. Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am J Physiol 1985, 249:R638-R641.
43. Grill HJ, Kaplan JM. The neuroanatomical axis for control of energy balance. Front Neuroendocrinol 2002, 23:2-40. 10.1006/frne.2001.0224, 11906202.
44. Caquineau C, Douglas AJ, Leng G. Effects of cholecystokinin in the supraoptic nucleus and paraventricular nucleus are negatively modulated by leptin in 24-h fasted lean male rats. J Neuroendocrinol 2010, 22:446-452. 10.1111/j.1365-2826.2010.01982.x, 2948420, 20163516.
45. Olson BR, Hoffman GE, Sved AF, Stricker EM, Verbalis JG. Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex. Brain Res 1992, 569:238-248. 10.1016/0006-8993(92)90635-M, 1371708.
46. Gaykema RPA, Goehler LE, Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav Immun 2004, 18:238-245. 10.1016/j.bbi.2003.08.002, 15050651.
47. Chun-xia YI, Li-qiang RU, Dao-song H. Transmission of gastric noxious signals to hypothalamus mediated by vagus nerve. Chin J Neurosci 2004, 20:353-356.
48. Patel KP, Zhang K, Kenney MJ, Weiss M, Mayhan WG. Neuronal expression of Fos protein in the hypothalamus of rats with heart failure. Brain Res 2000, 865:27-34. 10.1016/S0006-8993(00)02186-7, 10814730.
49. Wang X, Wang B-R, Zhang X-J, Zhen X, Ding Y-Q, Ju G. Evidences for vagus nerve in maintenance of immune balance and transmission of immune information from gut to brain in STM-infected rats. World J Gastroenterol 2002, 8:540-545.
50. Heidi EWD, Aldo B, Uslaner JM, Oates MM, Vittoz NM, Robinson TE, Watson SJ, Akill H. Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci 2001, 21:732-740.
51. Emmert MH, Herman JP. Differential forebrain c-fos mRNA induction by ether inhalation and novelty: evidence for distinctive stress pathways. Brain Res 1999, 845:60-67. 10.1016/S0006-8993(99)01931-9, 10529444.
52. Barbaccia ML. Much excitement about antidepressants, DBI and c-FOS. Pharmacol Res 2011, 64:333-335. 10.1016/j.phrs.2011.05.018, 21683143.
53. Rogers A, Schmuck G, Scholz G, Williams DC. c-fos mRNA expression in rat cortical neurons during glutamate-mediated excitotoxicity. Toxicol Sci 2004, 82:562-569. 10.1093/toxsci/kfh279, 15375295.
54. Rogers A, Schmuck G, Scholz G, Griffiths R, Meredith C, Schousboe A, Campiani G, Williams DC. Improvements in an in-vitro assay for excitotoxicity by measurement of early gene (c-fos mRNA) levels. Arch Toxicol 2005, 79:129-139. 10.1007/s00204-004-0617-5, 15565427.
55. Day HEW, Kryskow EM, Nyhuis TJ, Herlihy L, Campeau S. Conditioned fear inhibits c-fos mRNA expression in the central extended amygdala. Brain Res 2008, 1229:137-146. 2605076, 18634767.
56. Bel E, Silveira M, Graeff F, Garcia-Cairasco N, Guimarães F. Differential expression of c-fos mRNA and Fos protein in the rat brain after restraint stress or pentylenetetrazol-induced seizures. Cell Mol Neurobiol 1998, 18:339-346. 10.1023/A:1022505232618, 9590563.
57. Graybiel AM, Moratalla R, Robertson HA. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci 1990, 87:6912-6916. 10.1073/pnas.87.17.6912, 54648, 2118661.
58. Johnstone LE, Brown CH, Meeren HK, Vuijst CL, Brooks PJ, Leng G, JA R. Local morphine withdrawal increases c-fos gene, Fos protein, and oxytocin gene expression in hypothalamic magnocellular neurosecretory cells. J Neurosci 2000, 20:1272-1280.
59. Jin BK, Franzen L, Baker H. Regulation of c-Fos mRNA and fos protein expression in olfactory bulbs from unilaterally odor-deprived adult mice. Int J Dev Neurosci 1996, 14:971-982. 10.1016/S0736-5748(96)00044-5, 9010739.
60. Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 1995, 64:477-505. 10.1016/0306-4522(94)00355-9, 7700534.
61. Larsen PJ, Mikkelsen JD. Functional identification of central afferent projections conveying information of acute " stress" to the hypothalamic paraventricular nucleus. J Neurosci 1995, 15:2609-2627.
62. Campeau S, Watson SJ. Neuroendocrine and behavioral responses and brain pattern of c-fos induction associated with audiogenic stress. J Neuroendocrinol 1997, 9:577-588.
63. Lyte M, Li W, Opitz N, Gaykema RPA, Goehler LE. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 2006, 89:350-357. 10.1016/j.physbeh.2006.06.019, 16887154.
64. Tan Z, Nagata S. PVN c-fos expression, HPA axis response and immune cell distribution during restraint stress. J UOEH 2002, 24:131-149.
65. Girotti M, Pace TWW, Gaylord RI, Rubin BA, Herman JP, Spencer RL. Habituation to repeated restraint stress is associated with lack of stress-induced c-fos expression in primary sensory processing areas of the rat brain. Neuroscience 2006, 138:1067-1081. 10.1016/j.neuroscience.2005.12.002, 16431027.
66. Ostrander MM, Ulrich-Lai YM, Choi DC, Flak JN, Richtand NM, Herman JP. Chronic stress produces enduring decreases in novel stress-evoked c-fos mRNA expression in discrete brain regions of the rat. Stress 2009, 12:469-477. 10.3109/10253890802641966, 3676895, 20102318.
67. Melia KR, Ryabinin AE, Schroeder R, Bloom FE, MC W. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J Neurosci 1994, 14:5929-5938.
68. Ostrander MM, Ulrich-Lai YM, Choi DC, Richtand NM, Herman JP. Hypoactivity of the hypothalamo-pituitary-adrenocortical axis during recovery from chronic variable stress. Endocrinology 2006, 147:2008-2017. 1815381, 16396985.
69. Aisa B, Tordera R, Lasheras B, Del Río J, Ramírez MJ. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 2007, 32:256-266. 10.1016/j.psyneuen.2006.12.013, 17307298.
70. Ginsberg AB, Campeau S, Day HE, Spencer RL. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or Fos protein expression in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 2003, 15:1075-1083. 10.1046/j.1365-2826.2003.01100.x, 14622438.
71. Veening JG, Van Der Meer MJ, Joosten H, Hermus AR, Rijnnkels CE, Geeraedts LM, CG S. Intravenous administration of interleukin-1 beta induces Fos-like immunoreactivity in corticotropin-releasing hormone neurons in the paraventricular hypothalamic nucleus of the rat. J Chem Neuroanat 1993, 6:391-397. 10.1016/0891-0618(93)90013-T, 8142074.
72. Weiser MJ, Handa RJ. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009, 159:883-895. 10.1016/j.neuroscience.2008.12.058, 19166915.
73. Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005, 67:S26-S28. 10.1097/01.psy.0000163456.22154.d2, 15953796.
74. Abelson JL, Khan S, Liberzon I, Young EA. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 2007, 24:66-76. 10.1002/da.20220, 16845643.
75. Condren RM, O'Neill A, Ryan MCM, Barrett P, Thakore JH. HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinology 2002, 27:693-703. 10.1016/S0306-4530(01)00070-1, 12084662.
76. Martin EIRK, Binder E, Nemeroff CB. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin N Am 2009, 32:549-575.
77. Jaferi A, Bhatnagar S. Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic-pituitary-adrenal activity and anxiety-related behavior regardless of prior stress experience. Brain Res 2007, 1186:212-223. 2175080, 18001698.
78. Bethea CL, Lima FB, Centeno ML, Weissheimer KV, Senashova O, Reddy AP, Cameron JL. Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity. J Chem Neuroanat 2011, 41:200-218. 10.1016/j.jchemneu.2011.05.010, 3140797, 21683135.
79. Young EA, Altemus M, Parkison V, Shastry S. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 2001, 25:881-891. 10.1016/S0893-133X(01)00301-3, 11750181.
80. Puder JJ, Freda PU, Goland RS, Wardlaw SL. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. J Clin Endocrinol Metab 2001, 86:2403-2408. 10.1210/jc.86.6.2403, 11397831.
81. Walf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006, 31:1097-1111. 3624621, 16554740.
82. McIntyre RS, Mancini D, Eisfeld BS, Soczynska JK, Grupp L, Konarski JZ, Kennedy SH. Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology 2006, 31:1029-1035. 10.1016/j.psyneuen.2006.06.005, 16908107.
83. McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. Bju Int 2003, 91:69-74. 10.1046/j.1464-410X.2003.04016.x, 12614254.
84. Written WK. Occurrence of anoestrus in mice caged in groups. J Endocrinol 1959, 18:102-107. 10.1677/joe.0.0180102, 13620841.
85. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013, 18:666-673. 10.1038/mp.2012.77, 22688187.
86. Meziane H, Ouagazzal AM, Aubert L, Wietrzych M, Krezel W. Estrous cycle effects on behavior of C57BL/6 J and BALB/cByJ female mice: implications for phenotyping strategies. Genes Brain Behav 2007, 6:192-200. 10.1111/j.1601-183X.2006.00249.x, 16827921.
87. Võikar V, Kõks S, Vasar E, Rauvala H. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 2001, 72:271-281. 10.1016/S0031-9384(00)00405-4, 11240006.
88. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, MacQueen G, Sherman PM. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60:307-317. 10.1136/gut.2009.202515, 20966022.
89. Johnson-Henry KCNM, Avitzur Y, Mitchell DJ, Ngan B-Y, Galindo-Mata E, Jones NL, Sherman PM. Amelioration of the effects of citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis 2005, 191:2106-2117. 10.1086/430318, 15897997.